If the shutdown drags on at FDA, it will put anticipated new treatments in jeopardy
MICHAEL REYNOLDS/EPA
The agency only has about three more weeks’ worth of funding to draw down, after which it would have to suspend new drug approvals.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario